CME suggestions for pediatricians, allergists, and dermatologists, directed by an online survey on urticaria knowledge
Allergol. immunopatol
; 49(1): 87-94, ene.-feb. 2021. tab, graf
Artículo
en Inglés
| IBECS
| ID: ibc-199230
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
BACKGROUND:
The Mexican Guidelines for the diagnosis and treatment of urticaria have been published. Just before their launch, physicians' knowledge was explored relating to key issues of the guidelines.OBJECTIVE:
The aim of this study was to investigate the opinion of medical specialists concerning urticaria management.METHODS:
A SurveyMonkey(R) survey was sent out to board-certified physicians of three medical specialties treating urticaria. Replies were analyzed per specialty against the evidence-based recommendations.RESULTS:
Sixty-five allergists (ALLERG), 24 dermatologists (DERM), and 120 pediatricians (PED) sent their replies. As for diagnosis ALERG 42% and PED 76% believe cutaneous mastocytosis, urticarial vasculitis, and hereditary angioedema are forms of urticaria, versus DERM 29% (P < 0.005). Most of the specialties find that the clinical history and physical examination are enough to diagnose acute urticaria, except DERM 45% (P < 0.01). DERM 45% believe laboratory-tests are necessary, as opposed to <15% ALLERG-PED (P < 0.005). However, PED 69% did not know that the most frequent cause of acute urticaria in children is infections, versus ALLERG- DERM 30% (P < 0.005). Many erroneously do laboratory testing in physical urticaria and ALLERG 51%, DERM 59%, and PED 37% do extensive laboratory testing in chronic spontaneous urticaria (CSU); many more PED 59% take Immunoglobulin G (IgG) against foods (P < 0.005). More than half of non-allergists do not know about autologous serum testing nor autoimmunity (P < 0.05). As for treatment, there were a few major gaps when CSU was controlled, >75% prescribed antihistamines pro re nata, and > 85% gave first-generation antiH1 for insomnia. Finally, > 40% of DERM did not know that cyclosporine A, omalizumab, or other immunosuppressants could be used in recalcitrant cases.CONCLUSION:
Specialty-specific continuous medical education might enhance urticaria managementRESUMEN
No disponible
Texto completo:
Disponible
Colección:
Bases de datos nacionales
/
España
Base de datos:
IBECS
Asunto principal:
Pediatría
/
Urticaria
/
Dermatología
/
Educación Médica Continua
/
Alergia e Inmunología
Límite:
Humanos
Idioma:
Inglés
Revista:
Allergol. immunopatol
Año:
2021
Tipo del documento:
Artículo
Institución/País de afiliación:
Clinical Foundation and Hospital/México
/
Hospital con Especialidades Juan María Salvatierra/México
/
Hospital de Especialidades Juan María de Salvatierra/México